This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Dr. Mark Harfensteller

Chief Operating Officer ITM Group

Dr. Mark Harfensteller joined ITM as Head of Production and R&D in 2008. In 2016, he became Managing Director of ITM Medical Isotopes. Under Mark’s leadership, the company established an industrial and GMP compliant production, meeting the demand of the rapidly expanding radioisotope market. Prior to his work at ITM, Mark successfully completed a project at the Institute of Machine Tools and Industrial Management (TUM), focusing on the development and production of alpha-emitter, 225Ac, via the irradiation of 226Ra in a cyclotron. The project has been nominated for the “Deutscher Zukunftspreis”.

Mark holds a PhD in Mechanical Engineering from the Technical University of Munich (TUM) (Germany).